Bristol-Myers, AstraZeneca Face Damages

A federal court entered $12.9 million in damages against AstraZeneca PLC and $695,594 against Bristol-Myers Squibb Co. in a suit related to marketing the spread of certain drugs, according to law firms.
Wall Street Journal